Trans-translation is an unusual translation in which tmRNA plays a dual function as a tRNA and an mRNA to relieve the stalled translation on the ribosome. In this study, we examined the effects of an aminoglycoside antibiotic, paromomycin, on several tmRNA-related events in vitro. The results of a chemical footprinting study indicated that paromomycin molecules bind tmRNA at G332/G333 in the tRNA domain and A316 in the middle of the long helix between tRNA and mRNA domains. Paromomycin bound at G332/G333 inhibited aminoacylation, and the inhibition was suppressed by the addition of SmpB, a tmRNA binding protein. It was also found that paromomycin causes a shift of the translation-resuming point on tmRNA by -1. The effect on initiation-shift was canceled by a mutation at the paromomycin binding site in 16S rRNA, but not by mutations in tmRNA. A high concentration of paromomycin inhibited trans-translation, whereas it enhanced the initiation-shifted trans-translation when SmpB was exogenously added or a mutation was introduced at 333. The effect of paromomycin on trans-translation differs substantially from that on canonical translation, in which it induces miscoding by modulating the A site of the decoding helix of the small subunit RNA of the ribosome.
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SUMMARY
Trans-translation is an unusual translation in which tmRNA plays a dual function as a tRNA and an mRNA to relieve the stalled translation on the ribosome. In this study, we examined the effects of an aminoglycoside antibiotic, paromomycin, on several tmRNA-related events in vitro. The results of a chemical footprinting study indicated that paromomycin molecules bind tmRNA at G332/G333 in the tRNA domain and A316 in the middle of the long helix between tRNA and mRNA domains. Paromomycin bound at G332/G333 inhibited aminoacylation, and the inhibition was suppressed by the addition of SmpB, a tmRNA binding protein. It was also found that paromomycin causes a shift of the translation-resuming point on tmRNA by -1. The effect on initiation-shift was canceled by a mutation at the paromomycin binding site in 16S
rRNA, but not by mutations in tmRNA. A high concentration of paromomycin inhibited trans-translation, whereas it enhanced the initiation-shifted trans-translation when SmpB was exogenously added or a mutation was introduced at 333. The effect of paromomycin on trans-translation differs substantially from that on canonical translation, in which it induces miscoding by modulating the A site of the decoding helix of the small subunit RNA of the ribosome.
by guest on http://www.jbc.org/ Downloaded from INTRODUCTION tmRNA (transfer-messenger RNA, also known as 10Sa RNA or SsrA RNA) is widely distributed among eubacteria and has also been found in some chloroplasts and possibly in some mitochondria (1) (2) (3) (4) . It is a novel molecule with both tRNA and mRNA properties. The tRNA mimicry of the upper-half structure of this molecule has been shown by comparative studies (5-9), chemical and enzymatic probing studies (8, 10) , the presence of tRNA-specific modified nucleosides in the putative TΨC-loop (11) and the capacity to accept alanine (5, 6) . The mRNA domain, encoding the last ten amino acids of the 11-amino-acid tag-peptide, is surrounded by four pseudoknot structures in the middle of this molecule. The tag-peptide was first found at the C-terminus of a fraction of mouse interleukin-6 expressed in Escherichia coli (12) . Later, it was also found on other polypeptides when they are translated from artificial mRNAs lacking a termination codon (4) or possessing a cluster of rare codons (13) and from endogenous mRNAs in E. coli and Bacillus subtilis (14) (15) (16) .
It has been proposed that molecular interplay between these two functions of this molecule facilitates an unusual translation reaction -trans-translation-in which a ribosome can switch from the translation of a truncated mRNA to the tag-encoded sequence of tmRNA. This would relieve stalled translation from mRNAs lacking a stop codon or possessing a cluster of rare codons with the addition of a specific tag-peptide as a degradation signal to the truncated C-termini of polypeptides decoded (4, 7, 17, 18) .
This trans-translation model has also been supported by several other findings showing that the function as a tRNA is a prerequisite for the function as an mRNA in vitro (19) , that an amino acid aminoacylated to tmRNA is actually incorporated into the tagpeptide (20) and that tmRNA binds predominantly to 70S ribosomes (4, 21, 22) . A series of these processes may promote recycling of ribosomes and prevent accumulation of abortively synthesized polypeptides, providing some advantage to the cell for survival (16, 23, 24) . The mechanism by which tmRNA resumes translation from the first GCA codon for a tag-peptide is a central issue in the trans-translation. This resumption of translation is a mystery since it involves no apparent codon-anticodon interaction before the first translocation event. The first pseudoknot (PK1) 12 nucleotides upstream of the tag-initiation point, but not the other three pseudoknots (PK2-PK4) downstream of the tag-encoding region, has been shown to be important for efficient tag-translation (25) (26) (27) . It has also been shown both in vivo and in vitro that several nucleotides upstream of the tag-encoding region are involved in efficient tag-translation (28, 29) . Besides, some base substitutions around this region shift the tag-initiation point by -1 in vitro (29) .
Apart from the tag-encoding region, some nucleotides in the tRNA domain have been identified to be crucial for the mRNA function but not for the tRNA function (30) .
These sequences on tmRNA might have an intra-or intermolecular interaction to serve as a determinant for tag-translation. Several tmRNA-binding proteins such as EF-Tu (31) (32) (33) , SmpB (34, 35) and ribosomal protein S1 (36) have been identified, although how these proteins function in the ribosomal processes of trans-translation remains elusive.
In the present study, the effects of paromomycin, which belongs to a neomycinclass of aminoglycoside antibiotics, on several tmRNA-related events were examined in vitro. Paromomycin is known to interact with the A site of the decoding region of the 30S subunit of the ribosome to induce miscoding. In the present study, we found that paromomycin molecules bind tmRNA. We also found that it inhibits the aminoacylation of tmRNA and that it induces an initiation-shift of trans-translation. We identified which paromomycin molecule exerts each effect. The last effect was found to be caused not by paromomycins bound to tmRNA but by that bound to the decoding region of the ribosome. This effect differs substantially from that on canonical translation, in which paromomycin induces miscoding by modulating the decoding helix of the small subunit RNA of the ribosome. 
EXPERIMENTAL PROCEDURES
Preparation of tmRNA and its mutants -Mutations were introduced into the E. coli tmRNA gene by primer-directed polymerase chain reaction, and the amplified DNA fragment was ligated under the T7 RNA polymerase promoter sequence of the plasmid pGEMEX-2. This plasmid was cotransformed with pACYC184 encoding the T7 RNA polymerase gene under the lac-promoter sequence into E. coli strain W3110 ∆ssrA, which lacks the tmRNA gene (6) . tmRNA induced by the addition of 1.0 mM isopropyl-1-thio-β-D-galactopyranoside was purified as described previously (5) . The nucleic acid fraction was extracted with phenol from mid-log-phase cells followed by ethanol precipitation. After performing phenol extraction and ethanol precipitation, the resulting fraction was subjected to differential isopropylalcohol precipitations to roughly remove DNA, followed by incubation with RNase-free DNase I (Amersham Pharmacia Biotech). tmRNA was purified by electrophoresis on a 5% polyacrylamide gel containing 7M urea. Spectrophotometric measurements were made to determine the concentration of RNA. Ribosomes having the 1408G mutation in 16S rRNA -The 1408G mutation was introduced into the 16S rRNA gene on pKK3535 carrying the E. coli rrnB operon (39) using the primer-directed polymerase chain reaction. This plasmid was transformed into E. coli strain TA531 harboring two kinds of plasmids, pTRNA66 and pHK-rrnC 
RESULTS
Paromomycin molecules specifically bind tmRNA -Neomycin-class aminoglycosides often bind various RNA species to inhibit their functions. We first found that paromomycin, a neomycin-class aminoglycoside antibiotic, significantly increased the melting temperature of E. coli tmRNA (Table 1) . We then examined the binding of paromomycin to tmRNA using the chemical footprinting method. DMS, KE and CMCT methylate adenine/cytosine, guanine and uridine, respectively, at the Watson-Crick base-pair side, preferentially in the single strand region.
Various amounts of paromomycin were added to a reaction mixture of chemical modification. The chemically modified tmRNA was used as a template of reverse transcription. As shown in Figure 1 , the site of methylation can be identified on the gel, since the methylation stops the chain elongation of reverse transcription. The band of DMS modification at A316 and the bands of KE modification at G332 and G333 disappeared with an increase of the paromomycin concentration (Fig. 1b) . In contrast, the band intensity of DMS at A319 was increased (Fig. 1b) . No other significant changes in the band intensity were observed over the whole tmRNA molecule. These results
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indicate that paromomycin molecules bind tmRNA at A316, G332 and G333, enhancing the accessibility of DMS to A319.
We then prepared a tmRNA mutant in which A316 is substituted by C (316C).
In this mutant, the KE modification at G332 and G333 still decreased, whereas the DMS modification at A319 was not increased, with increase in the paromomycin concentration (Fig. 1b) . Since DMS mildly modifies the C residues, a faint band was able to be found at 316 in the mutant. The intensity of this band did not change with increase in the paromomycin concentration. We also prepared a 333C mutant in which an A-to-C substitution had been made at position 333. In this mutant, neither the band intensity of DMS modification at 332 nor KE modification at 333 decreased with increase in the paromomycin concentration, whereas a decrease and increase in band intensity was still observed at 316 and 319, respectively (Fig. 1b) . These results suggest that two different paromomycin molecules bind tmRNA in an independent manner, one to A316 and the other to G332/G333, and that the binding of a paromomycin molecule at A316 induces a local conformation change to enhance the accessibility of DMS to A319.
We next examined the effects of paromomycin on melting temperatures of 316C and 333C. As shown in Table 1 , the melting temperatures of these tmRNA mutants were similar to that of wild-type tmRNA in the absence of paromomycin. The addition of 5.5 µM or 55 µM paromomycin increased the melting temperatures of these two mutants, although the melting temperatures of the mutants were significantly lower than that of wild-type. We also prepared a double mutant 316C333C, in which paromomycin did not significantly increase the melting temperature. These results support the above-stated idea that two paromomycin molecules bind wild-type tmRNA, while only one binds 316C or 333C mutant.
Effects of paromomycin on aminoacylation of tmRNA in the presence or absence
of SmpB -We next examined the effects of paromomycin on aminoacylation of tmRNA 11 by alanyl-tRNA synthetase. Aminoacylation was significantly affected by the addition of paromomycin (Fig. 2a) . The addition of 550 µM paromomycin decreased the aminoacylation efficiency by about 60%.
It has been shown that SmpB, a tmRNA-binding protein, is essential for transtranslation (34) . It interacts with G19 and A334 or their surroundings in the lower portion of the tRNA domain of tmRNA to enhance aminoacylation efficiency, protect tmRNA from degradation in the cells and mediate ribosome binding to tmRNA (30, 35) .
The binding sites of SmpB and paromomycin appear to be close each other. As shown earlier, aminoacylation was enhanced by about four fold by the addition of 2 µM SmpB (Fig. 2a) . In the presence of 2 µM SmpB, more than 80% efficiency of aminoacylation remained even in the addition of 550 µM paromomycin. Apparently, SmpB suppressed the inhibition of aminoacylation by paromomycin.
Both the inhibition of aminoacylation and the suppression of the aminoacylation inhibition by SmpB were similarly observed when the 316C mutant was used instead of wild-type tmRNA (Fig. 2b) . In contrast, inhibition of aminoacylation was hardly observed when the 333C mutant was used (Fig. 2c) . The remaining aminoacylation efficiency after the addition of 550 µM paromomycin in the presence of SmpB (> 80%) was similar to that in the presence of SmpB.
These results indicate that the paromomycin molecule that bound at the lower portion of the tRNA domain around A334 inhibits the recognition by alanyl-tRNA synthetase and that the inhibition can be suppressed by SmpB.
Paromomycin causes an initiation-shift in the poly(U)-dependent trans-
translation in vitro -Himeno et al. (19) have developed an in vitro system of poly(U)-and exogenous tmRNA-dependent tag-peptide synthesis via trans-translation using the S30 fraction extracted from tmRNA-depleted cells. Amino acids comprising the tagpeptide are incorporated in the in vitro poly (U)-dependent polypeptide synthesis 12 system. Using this system, we can evaluate not only the efficiency of trans-translation but also the shift of the initiation point of tag-translation (29) . The tag-peptide from the normal initiation point (AANDENYALAA) contains five alanine residues. The tagpeptide from -1 (ARKRRKLRFSSLITCLEPSLPSLRS) contains one alanine residue, five arginine residues, five serine residues and one threonine residue. The tag-peptide from +1 (AQTTKTTL) contains one alanine and four threonine residues. In the present study, the effects of paromomycin on trans-translation were examined by measuring levels of alanine, arginine, glycine, serine and threonine incorporated in this system.
As shown earlier (19, 29) , amino acids were incorporated in a stoichiometrical fashion in the absence of paromomycin (Fig. 3a) . In the presence of 5.5 µM paromomycin, the level of alanine incorporation was slightly decreased, and, instead, a detectable level of arginine incorporation was generated. In the presence of 55 µM paromomycin, the effect was most pronounced. The level of alanine incorporation was decreased more, and, instead, significant levels of incorporation of typical -1 frame amino acids, arginine and serine, were observed. Glycine, which does not appear in any of three frames, was not detected. Considering the amino acid compositions of the tagpeptides of three frames, about 60% of the total tag-peptides was tag-peptides from position -1 and the remainder were the tag-peptide from the normal initiation point. At 550 µM paromomycin, levels of incorporation of amino acids, were significantly lower than those at 55 µM paromomycin. Such an inhibitory effect at a high concentration of paromomycin was not observed in phenylalanine incorporation (Fig. 3a, right column) representing the canonical translation from poly (U), which is prerequisite for transtranslation. (Fig. 3) , indicating that the amount of endogenous SmpB in the reaction mixture was sufficient.
Exogenous addition of
With an increase in the concentration of paromomycin, alanine incorporation decreased less dramatically than that without exogenous addition of SmpB (Fig. 3b) We next examined amino acid incorporations of 316C and 333C mutants to determine the effect of paromomycin binding to tmRNA on the initiation shift of transtranslation. As shown in Figure 4a , the 316C mutant had a pattern of amino acid incorporations quite similar to that for wild-type tmRNA at any concentration of paromomycin. The effect of a low concentration of paromomycin on 333C was also similar to that on wild-type tmRNA. These results indicate that the observed initiation shift of trans-translation was not caused by paromomycin binding to any of A316 and G333. Interestingly, at 550 µM paromomycin, the alanine incorporation of 333C was decreased more, and, in contrast, incorporations of -1 frame amino acids were significantly increased (Fig. 4b) . Apparently, the 333C mutation canceled the inhibitory effect of paromomycin on trans-translation. The pattern of amino acid incorporations was similar to that using wild-type tmRNA with 2 µM of exogenously added SmpB.
Judging from the ratio of amino acids incorporated, more than 80% of the transtranslation products were estimated to be -1 frame.
We also examined the effect of paromomycin on the deficient tag-translation directed by the 86C mutant having an A-to-C mutation four nucleotides upstream of the tag-initiation point. This mutant can associate with the ribosome as efficiently as wildtype tmRNA, although it has only a faint activity of trans-translation in vitro (29) .
Paromomycin did not induce any tag-related amino acid incorporations for the 86C mutant.
Lee et al. (29) have found several base-substitutions that cause a significant level of initiation shift of tag-translation by -1 in vitro. The 85A mutant having a U-to-A mutation five nucleotides upstream of the tag-initiation point is a typical initiationshift mutant. About 45% of the total tag-peptides from this mutant tmRNA is estimated to be initiated from -1. We examined the effects of paromomycin on the tag-translation directed by this mutant (Fig. 4c) . With increase in the paromomycin concentration, levels of amino acid incorporations became gradually decreased. However, the ratios of We therefore made an E. coli strain in which all the ribosomes have a 1408G mutation according to Asai et al. (40) , and we prepared 1408G mutant ribosomes to examine the effect of mutation on trans-translation. Cell-free trans-translation using the 1408G mutant ribosomes and the S100 fraction prepared from W3110∆ssrA cells was carried out.
Several differences were observed in the patterns of alanine and phenylalanine incorporations, compared with those using wild-type ribosomes (Fig. 5) . The ratio of alanine incorporation to phenylalanine incorporation was slightly lower in the absence of paromomycin. The addition of 5.5 µM paromomycin did not change, or even slightly enhanced, the alanine incorporation as well as the phenylalanine incorporation. Alanine incorporation decreased with an increase in paromomycin concentration, as was the case using wild-type ribosomes. Interestingly, basal levels of incorporations of -1 frame-tag amino acids, serine or arginine were detected at any concentration of paromomycin. The pattern of -1 frame-tag amino acid incorporations differed from that using wild-type ribosomes, the difference most apparent at 55 µM paromomycin (see and G333 are almost completely conserved. It has been proposed that G333 together with A334, G19 and A20 can form a sheared GA:GA base pair, a characteristic RNA structure (30, 49 ). An alternative tertiary structure model has also been proposed (50) . Further NMR and/or crystallographic studies will clarify the mode of binding of paromomycin molecules to tmRNA. with the D-and T-arms (G20, A23, A44 and G45) (49) .
The present results demonstrate that the binding of paromomycin to this region may also affect the binding of SmpB, which is consistent with an earlier finding that G332 and G333 are just at or close to the site of binding to SmpB (35, 52) . The 333C mutant should be free of this effect, probably leading to the pronounced initiation-shift at 550 µM paromomycin. The inhibitory effect of a high concentration of paromomycin seems specific to trans-translation rather than general to the translation, and either the 333C mutation or the addition of SmpB canceled this effect. This finding is consistent with the fact that SmpB serves as a trans-translation-specific factor, although it is not required for canonical translation (35) .
The shift in the resuming point of trans-translation seems to be a novel effect of paromomycin. The results of the present study revealed that it was caused not by binding of paromomycin to tmRNA but by modulation of the decoding region of the ribosome by paromomycin. Neomycin-class aminoglycosides typically induce miscoding of the translation via binding to the decoding region of the ribosomes (53).
They also induce a readthrough at the termination codon (54), inhibit the assembly of the 30S ribosomal subunit (55) , and inhibit the RRF-dependent disassembly of the post termination complex (56) . The readthrough at the termination codon often produces ribosomes stalled at the 3' end of mRNA, which would subsequently be released by The 1408G mutation in E. coli 16S rRNA has been shown to decrease the affinity of aminoglycosides to ribosomes and confer resistance to aminoglycosides upon cells (43, 64) . In the present study, the 1408G mutation conferred higher fidelity of the trans-translation initiation with a milder effect on efficiency of trans-translation in the presence of a low concentration of paromomycin (5.5 µM). At higher concentrations of paromomycin, a significant level of inhibition of trans-translation was still observed as in the case using wild-type ribosomes.
The mechanism by which tmRNA resumes translation from the first GCA codon for a tag-peptide remains unknown. The results of this study have revealed various effects of paromomycin on transtranslation. It has recently been shown that the lack of tmRNA increases sensitivity to some antibiotics in a cyanobacterium (68) and in E. coli (56) . Although the relevance between these in vivo effects and the in vitro effects revealed by the present study remains unknown, the results of further studies along these lines should lead to clarification of the molecular mechanism of trans-translation mediated by tmRNA. - Figure 1 
